September 18th, 2014
Fellows: Want to Blog for CardioExchange at AHA.14?
Harlan M. Krumholz, MD, SM and John Ryan, MD
CardioExchange editors Harlan Krumholz and John Ryan are looking for fellows to blog for CardioExchange at the American Heart Association Scientific Sessions from November 15th through the 19th in Chicago. If you are interested in blogging, please contact us. We look forward to hearing from you!
September 18th, 2014
Do Hemodynamic Endpoints Have Value in Patients Treated for Pulmonary Arterial Hypertension?
Corey E Ventetuolo, MD, MS
Corey E. Ventetuolo discusses her research group’s study of hemodynamic endpoints in clinical trials of patients with pulmonary arterial hypertension.
September 18th, 2014
FDA Approves New Once-Weekly GLP-1 Receptor Agonist for Type 2 Diabetes
Larry Husten, PHD
The FDA said today that it had approved dulaglutide, Lilly’s once-weekly injection to control blood sugar in adults with type 2 diabetes. The drug will be marketed under the brand name of Trulicity. The FDA said that the safety and efficacy of dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, had been studied in 3,342 type 2 diabetics. The […]
September 17th, 2014
Is It Safe to Offer PCI at VA Centers Without On-Site Cardiothoracic Surgery?
Thomas Maddox, MD MSc
Thomas M. Maddox discusses his research group’s study of post-PCI outcomes at VA centers with or without on-site cardiothoracic surgery.
September 15th, 2014
Cheaper Generic Statins Beat Brand-Name Statins in Adherence and Outcomes
Larry Husten, PHD
A large observational study finds that people who received a prescription for a generic statin were more likely to take their pills than people who received a prescription for a brand-name statin. This increased adherence appeared to lead to a small but significant improvement in outcomes. In a paper published in Annals of Internal Medicine, Joshua […]
September 15th, 2014
Selections from Richard Lehman’s Literature Review: September 15th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include prehospital ticagrelor in STEMI, ivabradine in stable CAD without clinical HF, FFR-guided PCI for stable CAD, and more.
September 15th, 2014
No Endorsement for Routine ECG Screening of Young People
Larry Husten, PHD
In a new scientific statement the American Heart Association and the American College of Cardiology do not recommend the routine initial use of ECGs to screen young people for underlying congenital or genetic heart disease. More aggressive screening for heart disease in young people is often advocated in response to pressure resulting from the rare […]
September 15th, 2014
New Observations on Saxagliptin
Benjamin Scirica, MD MPH
Benjamin Scirica discusses his study group’s new analysis of data from the SAVOR-TIMI 53 randomized, placebo-controlled trial of saxagliptin in patients with type 2 diabetes.
September 15th, 2014
How to Ace Your Fellowship Interview
Ethan J Weiss, M.D.
The following compilation of fellowship interview tips was originally published on Twitter between August 15th and 18th by Ethan Weiss, a cardiologist with 13 years of experience interviewing fellowship applicants. Matthew Pirotte also supplied this helpful graph categorizing potential applicants. 1. Prepare like you are interviewing for a job. You are. Know who you are meeting […]
September 11th, 2014
Race and Ethnicity Do Not Affect the Benefits of Device Therapy in Heart Failure
Boback Ziaeian, MD
Boback Ziaeian discusses his observational study exploring the benefits of guideline-recommended cardiac resynchronization therapy and ICD therapy in heart failure patients, according to race and ethnicity.